Abstract

BackgroundAmyloid beta (Aβ) is the main agent responsible for the advent and progression of Alzheimer's disease. This peptide can at least partially antagonize nerve growth factor (NGF) signalling in neurons, which may be responsible for some of the effects produced by Aβ. Accordingly, better understanding the NGF signalling pathway may provide clues as to how to protect neurons from the toxic effects of Aβ.ResultsWe show here that Aβ activates the RhoA GTPase by binding to p75NTR, thereby preventing the NGF-induced activation of protein tyrosine phosphatase 1B (PTP1B) that is required for neuron survival. We also show that the inactivation of RhoA GTPase and the activation of PTP1B protect cultured hippocampal neurons against the noxious effects of Aβ. Indeed, either pharmacological inhibition of RhoA with C3 ADP ribosyl transferase or the transfection of cultured neurons with a dominant negative form of RhoA protects cultured hippocampal neurons from the effects of Aβ. In addition, over-expression of PTP1B also prevents the deleterious effects of Aβ on cultured hippocampal neurons.ConclusionOur findings indicate that potentiating the activity of NGF at the level of RhoA inactivation and PTP1B activation may represent a new means to combat the noxious effects of Aβ in Alzheimer's disease.

Highlights

  • Amyloid beta (Ab) is the main agent responsible for the advent and progression of Alzheimer’s disease

  • Ab (1-42) induces morphological changes and regulates neuron survival via p75NTR/RhoA Previous studies revealed that Ab binds to p75NTR receptors [17,18], and more recent data indicates that p75NTR mediates the toxic effects of amyloid on cholinergic neurons [22,23]

  • We showed previously that the expression of Homologous of Enhancer-of-split 1 (Hes1) mRNA decreases when hippocampal neurons are exposed to Ab (5 μM for 4 h: Figure 1D)

Read more

Summary

Introduction

Amyloid beta (Ab) is the main agent responsible for the advent and progression of Alzheimer’s disease This peptide can at least partially antagonize nerve growth factor (NGF) signalling in neurons, which may be responsible for some of the effects produced by Ab. better understanding the NGF signalling pathway may provide clues as to how to protect neurons from the toxic effects of Ab. Results: We show here that Ab activates the RhoA GTPase by binding to p75NTR, thereby preventing the NGFinduced activation of protein tyrosine phosphatase 1B (PTP1B) that is required for neuron survival. Therapeutic approaches aimed at clearing Ab plaques have received special attention, and methods for active or passive immunisation have proven effective in reducing Ab content in the brain. These strategies have failed to conclusively ameliorate or retard cognitive deterioration in AD patients [4,5].

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call